786. Online CME Improves Adoption of Clinical Practice related to Incorporating long-acting Injectables into HIV Clinics

Abstract Background Recently, the first long-acting injectable (LAI) for the treatment of HIV was approved by the FDA. Although this advancement in therapeutics offers many potential advantages, including eliminating the needs for daily medications, the successful uptake into clinical settings will...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Open forum infectious diseases 2023-11, Vol.10 (Supplement_2)
Hauptverfasser: Thorpe, Sara, Blatherwick, Donald, Uravich, Maria B
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_2
container_start_page
container_title Open forum infectious diseases
container_volume 10
creator Thorpe, Sara
Blatherwick, Donald
Uravich, Maria B
description Abstract Background Recently, the first long-acting injectable (LAI) for the treatment of HIV was approved by the FDA. Although this advancement in therapeutics offers many potential advantages, including eliminating the needs for daily medications, the successful uptake into clinical settings will require navigating systems-level challenges such as clinic or hospital infrastructure. This study examined whether online continuing medical education (CME) focused on evidence-based best for incorporating long-acting injectables into clinical care would result in the adoption of new clinical practices. Methods Performance in the real world was assessed 30-60 days post-education for learners in the target audience(s). Email invitations were sent for the first 3 months of learners. Each respondent reported for each possible practice whether they were implementing for the first time or had modified it due to education, they were already doing it prior to education; or they were not doing it before or after education. They also indicated barriers they experience at least “some” of the time for each practice. The activity posted on 4/15/2022. Data was collection ended on 2/1/2023. Results There were a total of 39 learners consisting of PCPs, OB/GYNS, Nurses and NPs. Analysis showed that 80% of learners made a practice change or had practices reinforced due to education. Top 3 practice changes included:• 59% of learners are now educating eligible patients about the availability of LAI ART• 57% are staying abreast of current data from clinical trials, evaluating LAI ART for HIV• 56% are implementing LAI ART in clinical practice Survey results evidence persistent barriers to incorporating long-acting injectables into HIV Clinics. Top barriers included:• 38% Lack understanding of guidance about patient eligibility• 24% Lack knowledge of about best practices for getting started with LAI ART15% lack expertise in counseling patients on LAI ART Conclusion The clinical practice changes identified in this assessment provide compelling evidence that participation in online CME/CE prompts adoption of changes in practice related to incorporating LAI ART in the care of people with HIV. Future education is needed to address the barriers identified in this assessment. Disclosures All Authors: No reported disclosures
doi_str_mv 10.1093/ofid/ofad500.847
format Article
fullrecord <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_ofid_ofad500_847</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ofid/ofad500.847</oup_id><sourcerecordid>10.1093/ofid/ofad500.847</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1197-88af2e50348dc2913649a5dd56e7e346231d6e8b7460e5969fc57beb64774c0e3</originalsourceid><addsrcrecordid>eNqFkDtPwzAUhS0EElXpzugdpdhx_BqrqNBIRWUA1sixbypXqR05AcG_J1U7sLHce6TzGD6E7ilZUqLZY2y9m45xnJClKuQVmuUsV5nSXF7_0bdoMQwHQgilhBOpZ-hbKrHEu9D5ALh8WePq2Kf4BQNeudiPPgYcW1xOtremw6_J2NFbwAk6M4LDY8RVsDH1MZnRhz3uYthnp9Ckq3AAO5qmm-Z8mKKb6uOyNdyhm9Z0Aywuf47en9Zv5Sbb7p6rcrXNLKVaZkqZNgdOWKGczTVlotCGO8cFSGCFyBl1AlQjC0GAa6Fby2UDjSikLCwBNkfkvGtTHIYEbd0nfzTpp6akPsGrT_DqC7x6gjdVHs6V-Nn_n_4Fycdyfg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>786. Online CME Improves Adoption of Clinical Practice related to Incorporating long-acting Injectables into HIV Clinics</title><source>DOAJ Directory of Open Access Journals</source><source>Oxford Journals Open Access Collection</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Thorpe, Sara ; Blatherwick, Donald ; Uravich, Maria B</creator><creatorcontrib>Thorpe, Sara ; Blatherwick, Donald ; Uravich, Maria B</creatorcontrib><description>Abstract Background Recently, the first long-acting injectable (LAI) for the treatment of HIV was approved by the FDA. Although this advancement in therapeutics offers many potential advantages, including eliminating the needs for daily medications, the successful uptake into clinical settings will require navigating systems-level challenges such as clinic or hospital infrastructure. This study examined whether online continuing medical education (CME) focused on evidence-based best for incorporating long-acting injectables into clinical care would result in the adoption of new clinical practices. Methods Performance in the real world was assessed 30-60 days post-education for learners in the target audience(s). Email invitations were sent for the first 3 months of learners. Each respondent reported for each possible practice whether they were implementing for the first time or had modified it due to education, they were already doing it prior to education; or they were not doing it before or after education. They also indicated barriers they experience at least “some” of the time for each practice. The activity posted on 4/15/2022. Data was collection ended on 2/1/2023. Results There were a total of 39 learners consisting of PCPs, OB/GYNS, Nurses and NPs. Analysis showed that 80% of learners made a practice change or had practices reinforced due to education. Top 3 practice changes included:• 59% of learners are now educating eligible patients about the availability of LAI ART• 57% are staying abreast of current data from clinical trials, evaluating LAI ART for HIV• 56% are implementing LAI ART in clinical practice Survey results evidence persistent barriers to incorporating long-acting injectables into HIV Clinics. Top barriers included:• 38% Lack understanding of guidance about patient eligibility• 24% Lack knowledge of about best practices for getting started with LAI ART15% lack expertise in counseling patients on LAI ART Conclusion The clinical practice changes identified in this assessment provide compelling evidence that participation in online CME/CE prompts adoption of changes in practice related to incorporating LAI ART in the care of people with HIV. Future education is needed to address the barriers identified in this assessment. Disclosures All Authors: No reported disclosures</description><identifier>ISSN: 2328-8957</identifier><identifier>EISSN: 2328-8957</identifier><identifier>DOI: 10.1093/ofid/ofad500.847</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><ispartof>Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)</ispartof><rights>The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Thorpe, Sara</creatorcontrib><creatorcontrib>Blatherwick, Donald</creatorcontrib><creatorcontrib>Uravich, Maria B</creatorcontrib><title>786. Online CME Improves Adoption of Clinical Practice related to Incorporating long-acting Injectables into HIV Clinics</title><title>Open forum infectious diseases</title><description>Abstract Background Recently, the first long-acting injectable (LAI) for the treatment of HIV was approved by the FDA. Although this advancement in therapeutics offers many potential advantages, including eliminating the needs for daily medications, the successful uptake into clinical settings will require navigating systems-level challenges such as clinic or hospital infrastructure. This study examined whether online continuing medical education (CME) focused on evidence-based best for incorporating long-acting injectables into clinical care would result in the adoption of new clinical practices. Methods Performance in the real world was assessed 30-60 days post-education for learners in the target audience(s). Email invitations were sent for the first 3 months of learners. Each respondent reported for each possible practice whether they were implementing for the first time or had modified it due to education, they were already doing it prior to education; or they were not doing it before or after education. They also indicated barriers they experience at least “some” of the time for each practice. The activity posted on 4/15/2022. Data was collection ended on 2/1/2023. Results There were a total of 39 learners consisting of PCPs, OB/GYNS, Nurses and NPs. Analysis showed that 80% of learners made a practice change or had practices reinforced due to education. Top 3 practice changes included:• 59% of learners are now educating eligible patients about the availability of LAI ART• 57% are staying abreast of current data from clinical trials, evaluating LAI ART for HIV• 56% are implementing LAI ART in clinical practice Survey results evidence persistent barriers to incorporating long-acting injectables into HIV Clinics. Top barriers included:• 38% Lack understanding of guidance about patient eligibility• 24% Lack knowledge of about best practices for getting started with LAI ART15% lack expertise in counseling patients on LAI ART Conclusion The clinical practice changes identified in this assessment provide compelling evidence that participation in online CME/CE prompts adoption of changes in practice related to incorporating LAI ART in the care of people with HIV. Future education is needed to address the barriers identified in this assessment. Disclosures All Authors: No reported disclosures</description><issn>2328-8957</issn><issn>2328-8957</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNqFkDtPwzAUhS0EElXpzugdpdhx_BqrqNBIRWUA1sixbypXqR05AcG_J1U7sLHce6TzGD6E7ilZUqLZY2y9m45xnJClKuQVmuUsV5nSXF7_0bdoMQwHQgilhBOpZ-hbKrHEu9D5ALh8WePq2Kf4BQNeudiPPgYcW1xOtremw6_J2NFbwAk6M4LDY8RVsDH1MZnRhz3uYthnp9Ckq3AAO5qmm-Z8mKKb6uOyNdyhm9Z0Aywuf47en9Zv5Sbb7p6rcrXNLKVaZkqZNgdOWKGczTVlotCGO8cFSGCFyBl1AlQjC0GAa6Fby2UDjSikLCwBNkfkvGtTHIYEbd0nfzTpp6akPsGrT_DqC7x6gjdVHs6V-Nn_n_4Fycdyfg</recordid><startdate>20231127</startdate><enddate>20231127</enddate><creator>Thorpe, Sara</creator><creator>Blatherwick, Donald</creator><creator>Uravich, Maria B</creator><general>Oxford University Press</general><scope>TOX</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20231127</creationdate><title>786. Online CME Improves Adoption of Clinical Practice related to Incorporating long-acting Injectables into HIV Clinics</title><author>Thorpe, Sara ; Blatherwick, Donald ; Uravich, Maria B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1197-88af2e50348dc2913649a5dd56e7e346231d6e8b7460e5969fc57beb64774c0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thorpe, Sara</creatorcontrib><creatorcontrib>Blatherwick, Donald</creatorcontrib><creatorcontrib>Uravich, Maria B</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>CrossRef</collection><jtitle>Open forum infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thorpe, Sara</au><au>Blatherwick, Donald</au><au>Uravich, Maria B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>786. Online CME Improves Adoption of Clinical Practice related to Incorporating long-acting Injectables into HIV Clinics</atitle><jtitle>Open forum infectious diseases</jtitle><date>2023-11-27</date><risdate>2023</risdate><volume>10</volume><issue>Supplement_2</issue><issn>2328-8957</issn><eissn>2328-8957</eissn><abstract>Abstract Background Recently, the first long-acting injectable (LAI) for the treatment of HIV was approved by the FDA. Although this advancement in therapeutics offers many potential advantages, including eliminating the needs for daily medications, the successful uptake into clinical settings will require navigating systems-level challenges such as clinic or hospital infrastructure. This study examined whether online continuing medical education (CME) focused on evidence-based best for incorporating long-acting injectables into clinical care would result in the adoption of new clinical practices. Methods Performance in the real world was assessed 30-60 days post-education for learners in the target audience(s). Email invitations were sent for the first 3 months of learners. Each respondent reported for each possible practice whether they were implementing for the first time or had modified it due to education, they were already doing it prior to education; or they were not doing it before or after education. They also indicated barriers they experience at least “some” of the time for each practice. The activity posted on 4/15/2022. Data was collection ended on 2/1/2023. Results There were a total of 39 learners consisting of PCPs, OB/GYNS, Nurses and NPs. Analysis showed that 80% of learners made a practice change or had practices reinforced due to education. Top 3 practice changes included:• 59% of learners are now educating eligible patients about the availability of LAI ART• 57% are staying abreast of current data from clinical trials, evaluating LAI ART for HIV• 56% are implementing LAI ART in clinical practice Survey results evidence persistent barriers to incorporating long-acting injectables into HIV Clinics. Top barriers included:• 38% Lack understanding of guidance about patient eligibility• 24% Lack knowledge of about best practices for getting started with LAI ART15% lack expertise in counseling patients on LAI ART Conclusion The clinical practice changes identified in this assessment provide compelling evidence that participation in online CME/CE prompts adoption of changes in practice related to incorporating LAI ART in the care of people with HIV. Future education is needed to address the barriers identified in this assessment. Disclosures All Authors: No reported disclosures</abstract><cop>US</cop><pub>Oxford University Press</pub><doi>10.1093/ofid/ofad500.847</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2328-8957
ispartof Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)
issn 2328-8957
2328-8957
language eng
recordid cdi_crossref_primary_10_1093_ofid_ofad500_847
source DOAJ Directory of Open Access Journals; Oxford Journals Open Access Collection; EZB-FREE-00999 freely available EZB journals; PubMed Central
title 786. Online CME Improves Adoption of Clinical Practice related to Incorporating long-acting Injectables into HIV Clinics
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T06%3A10%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=786.%20Online%20CME%20Improves%20Adoption%20of%20Clinical%20Practice%20related%20to%20Incorporating%20long-acting%20Injectables%20into%20HIV%20Clinics&rft.jtitle=Open%20forum%20infectious%20diseases&rft.au=Thorpe,%20Sara&rft.date=2023-11-27&rft.volume=10&rft.issue=Supplement_2&rft.issn=2328-8957&rft.eissn=2328-8957&rft_id=info:doi/10.1093/ofid/ofad500.847&rft_dat=%3Coup_cross%3E10.1093/ofid/ofad500.847%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/ofid/ofad500.847&rfr_iscdi=true